TRex Bio, Inc.
No enriched coverage for $TRXB in the last 7 days.
SVLSF VI, LLC purchased 92,857 indirectly-held shares of TRex Bio, Inc. (TRXB) at $14.00 ($1.30M total) across 2 trades on 2026-10-08. Filed jointly with SV Life Sciences Fund VI (GP), L.P. (10% owner) and SV Life Sciences Fund VI, L.P. (10% owner).
In the last 30 days, TRXB insiders filed 2 SEC Form 4 transactions — 2 purchases ($1.3M) and no sales. The most active reporter was SVLSF VI, LLC with 2 filings.
Insider purchase suggests confidence and may support the stock price.
AlphAI scores every news story that mentions TRXB with an AI model for sentiment and relevance, and aggregates insider trades from TRex Bio, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
SVLSF VI, LLC purchased 92,857 indirectly-held shares of TRex Bio, Inc. (TRXB) at $14.00 ($1.30M total) across 2 trades on 2026-10-08. Filed jointly with SV Life Sciences Fund VI (GP), L.P. (10% owner) and SV Life Sciences Fund VI, L.P. (10% owner).
1 min read